Clinical Trial Update: First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of CSL040 in healthy subjects completed, evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics across escalating …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complement-mediated Disorders

Drugs mentioned

• CSL040

Snippet

Sponsor: CSL Behring | Conditions: Complement-mediated Disorders | Phase 1 | Status: COMPLETED